{"nctId":"NCT04235140","briefTitle":"Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation","startDateStruct":{"date":"2020-02-24","type":"ACTUAL"},"conditions":["Cystic Fibrosis"],"count":52,"armGroups":[{"label":"LUM/IVA","type":"EXPERIMENTAL","interventionNames":["Drug: LUM/IVA"]}],"interventions":[{"name":"LUM/IVA","otherNames":["lumacaftor/ivacaftor","VX-809/VX-770"]}],"eligibilityModule":{"eligibilityCriteria":"Key Inclusion Criteria:\n\n* Participants From Study VX16-809-122 Part B (Study 122)\n\n  * Completed the 24-week Treatment Period and the Safety Follow-up Visit in Study 122B\n* Participants Not From Study 122\n\n  * Subjects will be 1 to less than 2 years of age\n  * Homozygous for the F508del mutation (F/F)\n\nKey Exclusion Criteria:\n\n* Any clinically significant laboratory abnormalities that would interfere with the study assessments or pose an undue risk for the subject\n* Solid organ or hematological transplantation\n\nOther protocol defined Inclusion/Exclusion criteria may apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Months","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Absolute Change in Sweat Chloride (SwCl)","description":"Sweat samples were collected using an approved collection device.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.0","spread":"14.9"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":12,"n":52},"commonTop":["Cough","Upper respiratory tract infection","Pyrexia","Rhinorrhoea","Constipation"]}}}